• Balsalazide’s Prodrug Strategy in Ulcerative Colitis Remissi

  2026-05-09

  This article reviews the mechanistic and clinical advances presented by Wiggins and Rajapakse (2009) regarding balsalazide, a novel 5-aminosalicylate prodrug, in the treatment of active ulcerative colitis. The study’s findings demonstrate enhanced efficacy and tolerability relative to established 5-ASA therapies, with implications for inflammation research and translational approaches to gastrointestinal mucosal protection.

• Sorafenib (BAY-43-9006): Protocols and Innovations in Cancer

  2026-05-08

  Sorafenib (BAY-43-9006) stands out as a versatile cancer biology research tool, enabling precise dissection of kinase-driven pathways and antiangiogenic mechanisms. This guide details enhanced workflows, troubleshooting strategies, and recent cross-domain insights, positioning Sorafenib from APExBIO as a core reagent for both tumor modeling and cutting-edge host-directed antiviral studies.

• EZH2-Mediated Autophagy Inhibition Drives Neuropathic Pain i

  2026-05-08

  Meng et al. demonstrate that elevated EZH2 in anterior cingulate cortex microglia aggravates neuropathic pain after brachial plexus avulsion (BPA) by inhibiting autophagy, implicating the MTOR pathway. Autophagy inhibition using 3-Methyladenine confirms the mechanistic link, providing new insight into neuroinflammation and pain maintenance.

• Acetylcholine Chloride: Frontiers in Cholinergic Signaling R

  2026-05-07

  Explore the advanced scientific applications of Acetylcholine Chloride in cholinergic neurotransmission research. This article provides a deep dive into its mechanism, assay optimization, and insights from recent gut-brain axis discoveries.

• XPO1 Inhibition by Eltanexor Modulates Wnt/β-catenin in CRC

  2026-05-07

  This study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, effectively reduces colorectal cancer (CRC) tumorigenesis by modulating the Wnt/β-catenin signaling pathway and decreasing COX-2 expression. The findings highlight the chemopreventive potential of XPO1 inhibition in CRC and provide mechanistic insights for researchers developing targeted cancer therapeutics.

• CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti

  2026-05-06

  CUDC-907 is a dual PI3K and HDAC inhibitor formulated for in vitro research workflows targeting cancer cell signaling, especially where simultaneous inhibition of PI3K/AKT and histone deacetylase activity is required. It should be used strictly in controlled cell-based assay systems and is not appropriate for diagnostic or clinical applications.

• Lamotrigine in Cardiac and CNS Research: Novel Mechanistic H

  2026-05-06

  Explore Lamotrigine’s unique role as a sodium channel blocker and 5-HT inhibitor in both cardiac and CNS research. This article offers advanced insights into mechanistic selectivity, assay optimization, and cross-domain implications, setting a new benchmark for scientific rigor.

• Strategic Advances in Apoptosis and Akt Inhibition with Peri

  2026-05-05

  This article explores the mechanistic and translational potential of Perifosine (KRX-0401), a synthetic alkylphospholipid Akt inhibitor, in apoptosis and Akt/mTOR pathway research. Integrating recent advances in cancer and neuroprotection, the piece provides strategic guidance for translational researchers and positions APExBIO’s Perifosine as a critical tool for reproducibility and workflow optimization.

• MTT: Precision In Vitro Cell Proliferation and Viability Ass

  2026-05-05

  MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) stands as a gold-standard reagent for in vitro cell proliferation and metabolic activity quantification. This article details advanced workflows, troubleshooting, and protocol enhancements, with insights from the latest nanoparticle-based breast cancer stem cell research.

• KR-12 Human Antimicrobial Peptide: Assay Workflow & Troubles

  2026-05-04

  KR-12, the minimal active fragment of LL-37, stands out for its precise antimicrobial targeting, copper-binding characteristics, and low cytotoxicity. This article details advanced experimental workflows, troubleshooting insights, and protocol enhancements, empowering researchers to maximize the translational potential of KR-12 (human) TFA.

• Scenario-Driven Solutions with Methylprednisolone Sodium Suc

  2026-05-04

  This evidence-based article addresses real laboratory challenges in cell viability and inflammation research, illustrating how Methylprednisolone Sodium Succinate (SKU B4953) supports reproducible, high-sensitivity workflows. Practical Q&A scenarios guide researchers through protocol optimization, data interpretation, and vendor selection for robust results.

• γH2AX DNA Damage Detection: Bridging Mechanism to Applicatio

  2026-05-03

  Explore how precise γH2AX detection redefines translational research in DNA damage, radiotherapy response, and immune modulation—integrating mechanistic insights, leading-edge experimental evidence, and strategic guidance for researchers aiming to accelerate discoveries from bench to bedside.

• Dual Metabolic Reprogramming Boosts Ferroptosis in TNBC Ther

  2026-05-02

  This study introduces a metal-polyphenol nanoplatform that co-targets iron and lipid metabolism, advancing ferroptosis-based therapy for triple-negative breast cancer (TNBC). By unveiling compensatory resistance mechanisms and proposing dual inhibition of DHODH and DGAT1, the research provides a new framework for overcoming therapeutic resistance in aggressive cancers.

• Bismuth Subsalicylate: Strategic Insights for GI Translation

  2026-05-01

  Discover how Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) is reshaping gastrointestinal disorder research through advanced mechanistic understanding and practical translational strategies. This article offers a multidimensional perspective on inflammation pathway modulation, protocol optimization, and competitive positioning, grounded in evidence and actionable recommendations for researchers.

• Quercetin Modulates Glucose and Lipid Metabolism in GDM via

  2026-05-01

  This study identifies quercetin as a regulator of glucose and lipid metabolism in gestational diabetes mellitus (GDM) through modulation of the PCSK9/LDLR axis and activation of the PI3K/AKT/GSK3β pathway. The findings highlight both molecular and functional improvements in glucose uptake and lipid profiles, suggesting translational potential for metabolic disease research.

14574 records 1/972 page Next 12345 下5页 Last page